Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.91 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL25307085 | 1.00 | TSHR (0.91) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL14742964 | 1.00 | TSHR (0.91) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL24914 | 1.00 | TSHR (0.91) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1764683 | 1.00 | TSHR (0.91) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL3165957 | 1.00 | TSHR (0.91) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL1336519 | 0.96 | TSHR (0.83) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL7804043 | 0.96 | TSHR (0.83) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL2670537 | 0.96 | TSHR (0.83) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL10390162 | 0.96 | TSHR (0.83) | TSHRTP53CYP2C9PDE4ALMNA | |
| Cadaverine Tartrate SCHEMBL629997 | 0.96 | TSHR (0.83) | TSHRTP53CYP2C9PDE4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240334953-A1 | PACKAGED BEVERAGE HAVING SUPPRESSED OFFENSIVE TASTE AND ODOR ASSOCIATED WITH LACTIC ACID BACTERIA, AND METHOD FOR PRODUCING SAME | KIRIN BEVERAGE COMPANY, LIMITED (JP) | 2024-10-10 | — | — | US | disclosed |
| CN-118201497-A | Packaged beverage with suppressed odor and foreign odor caused by lactic acid bacteria, and its preparation method | 麒麟饮料株式会社 | 2024-06-14 | — | — | CN | disclosed |
| EP-4381959-A1 | PACKAGED BEVERAGE HAVING SUPPRESSED OFFENSIVE TASTE AND ODOR ASSOCIATED WITH LACTIC ACID BACTERIA, AND METHOD FOR PRODUCING SAME | Kirin Beverage Company, Limited (JP) | 2024-06-12 | — | — | EP | disclosed |
| WO-2023013364-A1 | PACKAGED BEVERAGE HAVING SUPPRESSED OFFENSIVE TASTE AND ODOR ASSOCIATED WITH LACTIC ACID BACTERIA, AND METHOD FOR PRODUCING SAME | キリンビバレッジ株式会社 | 2023-02-09 | — | — | WO | disclosed |
| EP-2082651-B1 | BEVERAGE PACKED IN CONTAINER | KAO CORP (JP) | 2015-08-05 | — | — | EP | disclosed |
| US-8652560-B2 | Packaged beverages | KAO CORPORATION (JP) | 2014-02-18 | — | — | US | disclosed |
| EP-2036446-B1 | CARBONATED BEVERAGE PACKED IN CONTAINER | KAO CORP (JP) | 2013-12-25 | — | — | EP | disclosed |
| EP-2098121-B1 | GREEN TEA DRINK PACKED IN CONTAINER | KAO CORP (JP) | 2013-09-18 | — | — | EP | disclosed |
| US-8455034-B2 | Green tea drink packed in container | KAO CORPORATION (JP) | 2013-06-04 | — | — | US | disclosed |
| US-8440246-B2 | Beverage packed in container | KAO CORPORATION (JP) | 2013-05-14 | — | — | US | disclosed |
| EP-2119374-A1 | BEVERAGE PACKED IN CONTAINER | Kao Corporation (JP) | 2009-11-18 | — | — | EP | disclosed |
| EP-2098121-A1 | GREEN TEA DRINK PACKED IN CONTAINER | Kao Corporation (JP) | 2009-09-09 | — | — | EP | disclosed |
| EP-2095727-A1 | PACKED DRINK | Kao Corporation (JP) | 2009-09-02 | — | — | EP | disclosed |
| US-20090191311-A1 | BEVERAGE PACKED IN FOAM CONTAINER | KAO CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| EP-2082651-A1 | BEVERAGE PACKED IN CONTAINER | Kao Corporation (JP) | 2009-07-29 | — | — | EP | disclosed |
| EP-2036446-A1 | BEVERAGE PACKED IN FOAM CONTAINER | KAO CORPORATION (JP) | 2009-03-18 | — | — | EP | disclosed |
| US-20080038408-A1 | PACKAGED BEVERAGES | KAO CORPORATION (JP) | 2008-02-14 | — | — | US | disclosed |
| US-5866162-A | ORAL ADMINISTERING | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-02-02 | — | — | US | disclosed |
| EP-0720476-A1 | PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/$g(b)-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE | SMITHKLINE BEECHAM PLC (GB) | 1996-07-10 | — | — | EP | disclosed |
| WO-1995004528-A2 | PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE | SMITHKLINE BEECHAM PLC (GB) | 1995-02-16 | — | — | WO | disclosed |